David Einhorn – GANX history
- Issuer:
- GAIN THERAPEUTICS INC
- Quarters tracked:
- 21 (Q1 2021 → Q1 2026)
- Current shares:
- 566,130
- Current value:
- $1.10M
- Peak shares:
- 588,410 (Q3 2023)
- Overall change:
- +4%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 566,130 | $1.10M | $1.94 | 0 | 0% |
| Q4 2025 | 566,130 | $1.82M | $3.22 | 0 | 0% |
| Q3 2025 | 566,130 | $1.00M | $1.77 | 0 | 0% |
| Q2 2025 | 566,130 | $1.02M | $1.80 | 0 | 0% |
| Q1 2025 | 566,130 | $1.08M | $1.91 | 0 | 0% |
| Q4 2024 | 566,130 | $1.22M | $2.16 | 0 | 0% |
| Q3 2024 | 566,130 | $1.01M | $1.78 | 0 | 0% |
| Q2 2024 | 566,130 | $725K | $1.28 | 0 | 0% |
| Q1 2024 | 566,130 | $2.13M | $3.77 | -22,280 | -4% |
| Q4 2023 | 588,410 | $1.92M | $3.26 | 0 | 0% |
| Q3 2023 | 588,410 | $1.93M | $3.28 | +41,850 | +8% |
| Q2 2023 | 546,560 | $2.45M | $4.48 | 0 | 0% |
| Q1 2023 | 546,560 | $2.63M | $4.82 | 0 | 0% |
| Q4 2022 | 546,560 | $1.71M | $3.13 | 0 | 0% |
| Q3 2022 | 546,560 | $1.78M | $3.26 | 0 | 0% |
| Q2 2022 | 546,560 | $1.97M | $3.60 | 0 | 0% |
| Q1 2022 | 546,560 | $2.24M | $4.09 | 0 | 0% |
| Q4 2021 | 546,560 | $2.97M | $5.43 | 0 | 0% |
| Q3 2021 | 546,560 | $4.07M | $7.44 | 0 | 0% |
| Q2 2021 | 546,560 | $5.47M | $10.00 | 0 | 0% |
| Q1 2021 | 546,560 | $8.15M | $14.92 | — | NEW |